BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14686928)

  • 1. The effect of mutations surrounding and within the active site on the catalytic activity of ricin A chain.
    Marsden CJ; Fülöp V; Day PJ; Lord JM
    Eur J Biochem; 2004 Jan; 271(1):153-62. PubMed ID: 14686928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine residues on the opposite side of the active site stimulate the catalysis of ribosome depurination by ricin A chain by interacting with the P-protein stalk.
    Li XP; Kahn PC; Kahn JN; Grela P; Tumer NE
    J Biol Chem; 2013 Oct; 288(42):30270-30284. PubMed ID: 24003229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ricin uses arginine 235 as an anchor residue to bind to P-proteins of the ribosomal stalk.
    Zhou Y; Li XP; Chen BY; Tumer NE
    Sci Rep; 2017 Feb; 7():42912. PubMed ID: 28230053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine 232 and hydrophobic residues at the ribosomal P stalk binding site are critical for biological activity of ricin.
    Zhou Y; Li XP; Kahn JN; McLaughlin JE; Tumer NE
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31548364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ricin A-chain substrate specificity in RNA, DNA, and hybrid stem-loop structures.
    Amukele TK; Schramm VL
    Biochemistry; 2004 May; 43(17):4913-22. PubMed ID: 15109249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of pokeweed antiviral protein and ricin A-chain on mutants in the alpha-sarcin loop of Escherichia coli 23S ribosomal RNA.
    Marchant A; Hartley MR
    J Mol Biol; 1995 Dec; 254(5):848-55. PubMed ID: 7500355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal Structure of Ribosome-Inactivating Protein Ricin A Chain in Complex with the C-Terminal Peptide of the Ribosomal Stalk Protein P2.
    Shi WW; Tang YS; Sze SY; Zhu ZN; Wong KB; Shaw PC
    Toxins (Basel); 2016 Oct; 8(10):. PubMed ID: 27754366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinyldeoxyadenosine in a sarcin-ricin RNA loop and its binding to ricin toxin a-chain.
    Roday S; Saen-oon S; Schramm VL
    Biochemistry; 2007 May; 46(21):6169-82. PubMed ID: 17477546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of ricin toxin A chain complexed with a highly potent pterin-based small-molecular inhibitor.
    Goto M; Sakamoto N; Higashi S; Kawata R; Nagatsu K; Saito R
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2219038. PubMed ID: 37259593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design.
    Sturm MB; Roday S; Schramm VL
    J Am Chem Soc; 2007 May; 129(17):5544-50. PubMed ID: 17417841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active center cleft residues of pokeweed antiviral protein mediate its high-affinity binding to the ribosomal protein L3.
    Rajamohan F; Ozer Z; Mao C; Uckun FM
    Biochemistry; 2001 Aug; 40(31):9104-14. PubMed ID: 11478877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of an amino acid residue outside the active site of the ricin A chain reduces its toxicity towards yeast ribosomes.
    Gould JH; Hartley MR; Welsh PC; Hoshizaki DK; Frankel A; Roberts LM; Lord JM
    Mol Gen Genet; 1991 Nov; 230(1-2):81-90. PubMed ID: 1745246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of in vitro and in vivo mutations in non-conserved nucleotides in the ribosomal RNA recognition domain for the ribotoxins ricin and sarcin and the translation elongation factors.
    Macbeth MR; Wool IG
    J Mol Biol; 1999 Jan; 285(2):567-80. PubMed ID: 9878430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of a disulfide bond into ricin A chain decreases the cytotoxicity of the ricin holotoxin.
    Argent RH; Roberts LM; Wales R; Robertus JD; Lord JM
    J Biol Chem; 1994 Oct; 269(43):26705-10. PubMed ID: 7929403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and activity of an active site substitution of ricin A chain.
    Day PJ; Ernst SR; Frankel AE; Monzingo AF; Pascal JM; Molina-Svinth MC; Robertus JD
    Biochemistry; 1996 Aug; 35(34):11098-103. PubMed ID: 8780513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-domain antibodies neutralize ricin toxin intracellularly by blocking access to ribosomal P-stalk proteins.
    Czajka TF; Vance DJ; Davis S; Rudolph MJ; Mantis NJ
    J Biol Chem; 2022 Apr; 298(4):101742. PubMed ID: 35182523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage between substrate recognition and catalysis during cleavage of sarcin/ricin loop RNA by restrictocin.
    Korennykh AV; Plantinga MJ; Correll CC; Piccirilli JA
    Biochemistry; 2007 Nov; 46(44):12744-56. PubMed ID: 17929942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of recombinant ricin A chain at 2.3 A.
    Mlsna D; Monzingo AF; Katzin BJ; Ernst S; Robertus JD
    Protein Sci; 1993 Mar; 2(3):429-35. PubMed ID: 8453380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.
    Fu T; Burbage C; Tagge E; Chandler J; Willingham M; Frankel A
    Bioconjug Chem; 1996; 7(6):651-8. PubMed ID: 8950484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based identification of determinants of conformational and spectroscopic change at the ricin active site.
    Carra JH; McHugh CA; Mulligan S; Machiesky LM; Soares AS; Millard CB
    BMC Struct Biol; 2007 Nov; 7():72. PubMed ID: 17986339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.